Search Results - "Ferreira, Fabio O."

A phase 2 study of first‐line nivolumab in patients with locally advanced or metastatic cutaneous squamous‐cell carcinoma by Munhoz, Rodrigo R., Nader‐Marta, Guilherme, Camargo, Veridiana P., Queiroz, Marcello M., Cury‐Martins, Jade, Ricci, Hermínia, Mattos, Marcela R., Menezes, Thiago A. F., Machado, Guilherme U. C., Bertolli, Eduardo, Barros, Milton, Souza, Carina E., Franke, Fábio, Ferreira, Fabio O., Feher, Olavo, Castro, Gilberto

“…Background Cutaneous squamous‐cell carcinoma (CSCC) is among the most frequent malignancies worldwide. For those not amenable to treatment with curative…”
Get full text

Discordance Between the Initial Diagnosis of Sarcomas and Subsequent Histopathological Revision and Molecular Analyses in a Sarcoma Reference Center in Brazil by Lopes, Carlos Diego H, Queiroz, Marcello M, Sampaio, Luana A F, Perina, André, Akaishi, Eduardo, Teixeira, Jr, Frederico, Ferreira, Fábio de O, Hanna, Samir A, da Silva, João Luís F, De Lima, Luiz Guilherme C A, de Oliveira, Claudia Regina G C M, Munhoz, Rodrigo R

“…To investigate the discordance in sarcoma diagnoses between nonspecialized institutions following revision by dedicated sarcoma pathologists at a reference…”
Get full text

ErbB family immunohistochemical expression in colorectal cancer patients with higher risk of recurrence after radical surgery by Baiocchi, Glauco, Lopes, Ademar, Coudry, Renata A, Rossi, Benedito M, Soares, Fernando A, Aguiar, Samuel, Guimarães, Gustavo C, Ferreira, Fabio O, Nakagawa, Wilson T

“…Purpose Investigate ErbB family expression in colorectal cancer patients with higher risk of recurrence after surgical treatment. Methods We studied 109…”
Get full text

Neoadjuvant Hypofractionated Radiotherapy and Chemotherapy in High-Grade Extremity Soft Tissue Sarcomas: Phase 2 Clinical Trial Protocol by Spencer, Ranyell Msb, Aguiar Junior, Samuel, Ferreira, Fabio O, Stevanato Filho, Paulo R, Kupper, Bruna Ec, Silva, Maria Lg, Mello, Celso A, Bezerra, Tiago S, Lopes, Ademar

“…Neoadjuvant radiotherapy (RT) and chemotherapy are applied to large, high-grade extremity soft tissue sarcomas to treat metastatic disease earlier and…”
Get full text

Breakpoint characterization of a novel large intragenic deletion of MUTYH detected in a MAP patient: case report by Torrezan, Giovana T, da Silva, Felipe C C, Krepischi, Ana C V, Santos, Érika M M, Ferreira, Fábio de O, Rossi, Benedito M, Carraro, Dirce M

“…MUTYH-associated polyposis (MAP) is a recessive, hereditary, colorectal cancer-predisposing syndrome caused by biallelic mutations in the MUTYH gene. Most…”
Get full text

Chemoradiation instead of surgery to treat mid and low rectal tumors: is it safe? by Nakagawa, Wilson T, Rossi, Benedito M, de O Ferreira, Fábio, Ferrigno, Robson, David Filho, Waldec J, Nishimoto, Inês N, Vieira, Rene A C, Lopes, Ademar

“…The main treatment for rectal carcinoma is surgery. Preoperative chemoradiation (CRT) is advocated to reduce local recurrence and improve resection of mid and…”
Get full text

Double-barreled wet colostomy is a safe option for simultaneous urinary and fecal diversion. Analysis of 56 procedures from a single institution by Guimaraes, Gustavo C., Ferreira, Fabio O., Rossi, Benedito M., Aguiar Jr, Samuel, Zequi, Stenio C., Bachega, Wilson, Nakagawa, Wilson T., Fonseca, Francisco P., Sarkis, Alvaro S., Lopes, Ademar

“…Background and Objectives Wide pelvic tumors need urinary and fecal diversion. We set out to assess the efficacy of the double‐barreled wet colostomy (DBWC) in…”
Get full text

Surgical complications and metachronous rectal cancer risk in patients with classic familial adenomatous polyposis by Stevanato Filho, Paulo Roberto, Aguiar, Samuel, Ferreira, Fábio O, Nakagawa, Wilson T, Spencer, Ranyell M, Takahashi, Renata M, Bezerra, Tiago S, Lopes, Ademar

“…Abstract Introduction Familial adenomatous polyposis (FAP), an autosomal dominant disease characterized by development of numerous adenomatous polyps in the…”
Get full text

Abstract 18: Molecular characterization of Brazilian patients suspected for Lynch syndrome by Silva, Felipe C., Torrezan, Giovana T., Figueiredo, Márcia CP, Ferreira, Jose Roberto O., Santos, Érika M., Nakagawa, Wilson T., Aguiar-Junior, Samuel, Rossi, Benedito M., Ferreira, Fabio O., Carraro, Dirce M.

“…Lynch syndrome (LS), former known as Hereditary Non Polyposis Colorectal cancer (HNPCC), accounts for 3-5% of all colorectal cancers (CRC) and is inherited in…”
Get full text

Abstract 2108: Prevalence of mutations in MSH6, PMS1 and PMS2 gene in Brazilian families with Lynch syndrome by Silva, Felipe C., Torrezan, Giovana T., Lisboa, Bianca G., Santos, Erika M., Gomy, Israel, Rossi, Benedito M., Ferreira, Fabio O., Carraro, Dirce M.

“…Background: Lynch syndrome (LS) is an autosomal dominant disorder predisposing to colorectal cancer and increased risk for cancers of the stomach, small…”
Get full text

Prognostic factors in locally advanced colon cancer treated by extended resection by Vieira, René A C, Lopes, Ademar, Almeida, Paulo A C, Rossi, Benedito M, Nakagawa, Wilson T, Ferreira, Fabio O, Melo, Celso A

“…The impact of clinical, pathologic, and surgical variables on the postoperative morbidity, mortality, and survival of patients undergoing extended resections…”
Get full text